IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report) had its price target decreased by research analysts at Truist Financial from $63.00 to $59.00 in a report released on Wednesday,Benzinga reports. Get IDEAYA Biosciences alerts:Get Our Latest Analysis on IDYAIDEAYA Biosciences Price PerformanceNASDAQ IDYA traded up $0.23 during trading on Wednesday, hitting $36.34. As a group, analysts expect that IDEAYA Biosciences will post -4.1 earnings per share for the current fiscal year. IDEAYA Biosciences Company Profile(Get Free Report)IDEAYA Biosciences is a clinical-stage precision oncology company dedicated to the discovery and development of novel therapies that exploit synthetic lethality in cancer cells. Further ReadingReceive News & Ratings for IDEAYA Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEAYA Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.